Events

CEO Forum: Lessons from the Frontlines of Medtech Innovation

October 22, 2024
12:00 PM – 1:00 PM

Register now

Join AdvaMed and Sunrise Labs for this timely webinar on the medtech industry, its breakthroughs and challenges.

CEO Forum: Lessons from the Frontlines of Medtech Innovation

October 22, 2024
12:00 PM – 1:00 PM

Register now

  1. Overview
  2. Speakers

CEO Forum: Lessons from the Frontlines of Medtech Innovation

October 22, 2024
12:00 PM – 1:00 PM

Register now

The medtech industry is at a crossroads, confronted with the tremendous potential of breakthrough diagnostics and therapies coupled with the promise of digital technology but challenged by regulatory, reimbursement and limited fund-raising options. This CEO Forum, hosted by AdvaMed, brings together three industry leaders busy overcoming today’s health care innovation challenges. By sharing insights and perspectives, the panel will explore strategies for leading medtech start-up companies to deliver meaningful innovation to our healthcare system.

Join us virtually on October 22 at 12:00 PM ET to explore the medtech industry and strategies for leading medtech start-up companies to deliver meaningful innovation to our health care system.

Meet The Speaker

Bryan Gilpin, President, Sunrise Labs, Inc.

Bryan has spent his career building and growing great organizations to deliver technology that improves lives around the world. Prior to his appointment as President at Sunrise Labs, Bryan held leadership positions as President and Chief Operating Officer of Intuvie, LLC, a mid-size drug infusion pump and software company. At Haemonetics (NYSE: HAE), he led the global launch of a break-through apheresis technology with integrated, cloud-based software. Bryan held various roles of increasing responsibility at Boston Scientific in product management and operations. He holds an MSEE and an MBA from MIT and a BS in Computer Engineering from the University of Illinois.

Jonathan Gunn, PhD CEO, Briteseed

Jonathan is an expert in medical imaging and founded Briteseed to deliver hyperspectral imaging to the operating room. By integrating optics into minimally invasive tools, Briteseed enables surgeons to identify and visualize critical structures that are otherwise invisible to the human eye. Jonathan received his doctoral degrees in Biomaterials Engineering & Nanotechnology from the University of Washington, his JD from Northwestern Law, and joined distinguished patent law firm, Fish & Richardson, prior to starting Briteseed.

Mark Pacyna, CEO, Reprieve Cardiovascular

Mark has been CEO of Reprieve Cardiovascular since May 2021.  Reprieve is a startup in the Acute Decompensated Heart Failure space developing a personalized intelligent decongestion management solution.   Prior to joining Reprieve, Mark spent 16 years with Medtronic in various leadership positions.   Most recently, Mark served as the VP & General Manager of Medtronic’s Peripheral Vascular Business.   He also held several leadership roles in Strategy & Business Development, Corporate Development, and Sales Leadership across Medtronic’s Cardiovascular and Spine businesses.   Mark graduated with a BSB in Management Information Systems from the University of Minnesota Carlson School of Business and an MBA from the University of Michigan.

Hear From Us

Sign up to receive emails highlighting our upcoming events, early registration savings, and engagement opportunities for the medical technology community.